Selling Recovery Across Borders: TENTIAL’s BAKUNE and the Challenge of Brand Translation

How a Japanese recovery-wear brand is navigating different regulatory systems, consumer habits, premium pricing, and business partnerships as it expands internationally.

A pair of pajamas priced at more than $250 is not an everyday purchase for most consumers. Convincing someone to pay that much requires a compelling explanation of what makes the product different.

For Japanese brand TENTIAL, that explanation comes with an additional complication. Its signature recovery wear, BAKUNE, is sold in Japan as a general medical device, a regulatory classification that does not automatically carry over to the United States.

TENTIAL has begun building its international presence, with online stores serving the U.S., Singapore, and Taiwan. It has also moved beyond direct-to-consumer sales, developing partnerships with airlines, hotels, and, more recently, a major American university baseball program.

Together, these developments offer an interesting view of a challenge facing many brands entering international markets: how to preserve a product’s original value while making it credible and commercially relevant to a different audience.

From Japanese Recovery Wear to International Markets

Founded in 2018 and headquartered in Tokyo, TENTIAL is a publicly listed Japanese company focused on conditioning products for everyday well-being. Its best-known product, BAKUNE, was introduced in February 2021.

BAKUNE is designed as functional sleepwear using SELFLAME®, a proprietary fiber that, according to TENTIAL, reflects far-infrared energy emitted by the body to promote blood circulation and support recovery from everyday fatigue.

In Japan, the brand operates within an established regulatory framework for this type of product.

In October 2022, Japan’s Ministry of Health, Labour and Welfare established the medical-device category known as Household Far-Infrared Clothing for Promoting Blood Circulation (Japanese regulatory category for household far-infrared circulation-promoting garments).

Eligible BAKUNE garments are notified as Class I general medical devices under this category.

There is an important distinction here. Japan’s Class I system requires a notification, rather than an individual product approval following a regulatory review of efficacy. The Pharmaceuticals and Medical Devices Agency (PMDA) states that it does not review the contents of these notifications. Manufacturers remain responsible for meeting applicable requirements, including relevant standards.

That classification gives TENTIAL a defined framework for communicating certain intended effects in Japan. It does not, however, establish the product’s regulatory status in another country.

What Changes When the Product Reaches the U.S.?

A comparison of TENTIAL’s Japanese and American websites reveals a difference in how the product is introduced.

The Japanese website leads with a direct functional proposition: wearing recovery wear to promote circulation and relieve fatigue.

The U.S. website uses a more lifestyle-oriented entry point:

“Recovery Starts With Pajamas.”

It encourages consumers to reconsider their sleep environment, including the clothing closest to their skin.

The underlying functional message has not disappeared. The American site still discusses circulation and recovery, while referring to BAKUNE’s general medical-device status in Japan.

What differs is the emphasis.

The Japanese presentation foregrounds the product’s functional benefits within a familiar domestic regulatory category. The American presentation also connects those benefits to a broader conversation about sleep habits and everyday recovery.

This comparison alone does not prove that TENTIAL deliberately designed a different positioning strategy for the U.S.

However, the company’s leadership has publicly acknowledged the need for market-specific adaptation.

In a January 2026 interview with FASHIONSNAP, CEO Yutaro Nakanishi discussed TENTIAL’s overseas initiatives, including cross-border e-commerce and a Shanghai pop-up. He explained that medical-device regulations differ by country, requiring adjustments to marketing approaches.

That observation has practical implications.

In the United States, the Food and Drug Administration evaluates whether a product is regulated as a medical device based on factors including its intended use and claims. Separately, the Federal Trade Commission requires health-related advertising claims to be truthful, nonmisleading, and supported by appropriate scientific evidence.

A Japanese medical-device notification cannot substitute for compliance with U.S. requirements. This article does not make a determination about BAKUNE’s specific FDA classification or registration status.

For international brands, the challenge extends beyond regulatory terminology. Product claims, supporting evidence, and the way benefits are explained to consumers all need to work within the destination market.

A Premium Product Also Needs a Reason to Exist

Regulatory compliance is only one part of the equation. Consumers must also understand why the product deserves its price.

As of October 11, 2026, TENTIAL’s U.S. online store listed a BAKUNE Dry women’s long-sleeve set at $250 and a BAKUNE Sweat men’s long-sleeve set at $270.

At these prices, BAKUNE is competing for discretionary spending well beyond the cost of basic sleepwear.

Its value proposition depends on consumers appreciating some combination of functionality, material quality, comfort, design, and recovery-related benefits.

This creates a market-entry question that product specifications alone cannot answer: does the target customer already consider specialized sleepwear worth paying for?

An account from TENTIAL’s partnership with Stanford University offers a useful illustration.

Stanford University: A Different Kind of Market Entry

In July 2026, TENTIAL announced a conditioning-support agreement with Stanford University’s baseball program in California.

Under the agreement, the team adopted BAKUNE Mesh recovery wear and a collaborative version of TENTIAL’s Tex Sweat full-zip hoodie.

According to TENTIAL, the decision followed approximately 12 months of product trials and player feedback. The company also reported that Stanford’s coaching and sports medical staff reviewed scientific materials, including clinical data supplied by TENTIAL.

These details are significant from a business-development perspective.

Rather than relying solely on consumer advertising, TENTIAL placed its products in an environment where physical recovery is closely connected to daily performance.

The university partnership also involved an evaluation process. While TENTIAL’s account does not independently establish the clinical effectiveness of BAKUNE, it shows how the company presented its product to a professional audience with specific performance and conditioning concerns.

Another detail is particularly revealing.

In an interview published by TENTIAL, Japanese baseball player Rintaro Sasaki, who was then playing for Stanford, described his initial uncertainty about introducing BAKUNE to his teammates.

He noted that some American players slept wearing only underwear and were not especially accustomed to thinking about pajamas as part of their recovery routine.

According to Sasaki, the response after teammates tried BAKUNE was positive.

His comments describe the habits of people around him, not American consumers generally. Still, they highlight an important distinction between introducing a product and introducing a new behavior.

If specialized sleepwear is not already part of a customer’s routine, the brand must first establish why the category deserves attention.

That is a different marketing challenge from persuading an existing recovery-wear customer to switch brands.

Stanford provides a concrete example of TENTIAL’s activity in the American market. It does not yet demonstrate broader U.S. consumer adoption or sustained commercial growth.

Building Credibility Through Experience

TENTIAL’s work with institutional partners began well before its Stanford announcement.

In April 2024, the company started collaborating with ANA Business Jet, providing conditioning products to selected private-jet passengers.

The relationship subsequently expanded within the ANA group.

In July 2025, ANA introduced BAKUNE on selected international First Class flights departing Haneda for New York and San Francisco, initially as a limited trial.

On March 12, 2026, ANA announced that it would extend the program to all its international First Class routes from around April. ANA attributed the decision to favorable passenger feedback and requests for the product’s return.

The expanded program uses different BAKUNE styles depending on route and departure location, integrating the garments into ANA’s existing premium onboard service.

TENTIAL has also pursued hospitality partnerships, including Six Senses Kyoto, where a special version of BAKUNE was introduced across guest rooms in November 2024.

The hotel offered guests the opportunity to purchase the product through its boutique, connecting an in-room experience with retail.

At ROKU KYOTO, an initial installation in two suites in December 2025 was followed by an expansion to premier-floor rooms in October 2026.

The common element is the setting.

Rest is already central to the customer experience in a hotel room, on a long-distance flight, or within a competitive sports program.

Introducing recovery wear in these environments may make its intended value easier to understand through direct use.

For a premium brand, that can be more persuasive than asking consumers to make a purchasing decision based entirely on product descriptions.

Nevertheless, these partnerships primarily document product adoption by institutional customers. The airline and hotel examples are centered in Japan and should not be interpreted as evidence of TENTIAL’s commercial success in the U.S.

The Less Visible Challenge: Making Partnerships Work

High-profile partnerships attract attention, but operational compatibility often determines whether they are commercially sustainable.

TENTIAL has discussed these difficulties openly.

In a November 2024 interview published on its official note, the company’s B2B representative, Tomoko Ralston, explained that hotels can impose requirements that consumer products were never designed to meet.

Some require compatibility with commercial laundry equipment. Others have procurement rules that exclude household products or demand custom specifications.

Products worn directly against the skin also create practical concerns around hygiene, sharing, and reuse.

Cost is another obstacle.

Ralston noted that hotels might typically budget around ¥4,000–¥5,000 for a pajama set, while BAKUNE cost approximately ¥20,000 at the time.

Convincing a hotel to spend four or five times more requires a business case that extends beyond the garment itself.

The product must contribute something meaningful to the guest experience, hotel positioning, or service offering.

A similar issue emerged in TENTIAL’s collaboration with ANA. In a May 2026 company interview, TENTIAL explained that changing even one onboard item affects the responsibilities and workflow of multiple airline employees.

Introducing a new product therefore requires coordination across an established service operation.

These are familiar challenges in international business development. A product may be attractive to consumers while remaining difficult for distributors, retailers, or corporate partners to adopt.

The commercial proposition must work for the partner as well as the end user.

What the TENTIAL Case Tells Us About International Expansion

TENTIAL’s international activities remain a developing story. Its regional e-commerce presence, Stanford agreement, and institutional partnerships show how the company is presenting and introducing its products in different contexts.

They do not, on their own, establish the scale or profitability of its overseas business. The sources examined for this article do not provide sufficient market-specific sales and customer-retention data to assess those outcomes.

Even so, the case reveals several practical considerations for companies entering foreign markets.

Regulatory credibility must be understood in local terms. A product classification that carries meaning in Japan may require different explanations, supporting evidence, and compliance procedures elsewhere.

Consumer behavior matters as much as product functionality. Where a product requires a change in habit, educating consumers about the category may be necessary before communicating the advantages of a particular brand.

Premium positioning needs context. The question is not simply whether consumers can afford a product. They must see sufficient value in its benefits and understand why it belongs in their lives.

Partnerships require operational fit. An airline, hotel, or sports organization may provide a relevant environment for product experience, but procurement requirements, service standards, and implementation costs remain decisive.

For Japanese brands, a successful domestic track record provides a useful starting point. It also creates assumptions that need to be tested: about what customers value, which claims they trust, how products fit into their routines, and what distribution partners are prepared to support.

The reverse is equally relevant to international brands entering Japan.

TENTIAL’s case suggests that effective brand translation begins with understanding which parts of a product’s value are already meaningful to customers in the destination market—and which parts still need to be established.

A product can cross borders unchanged. The reasons people believe in it, use it, and pay for it may not.

Sources and References

• TENTIAL — Corporate Overview
• TENTIAL — Japan Recovery Wear Overview (Japanese)
• TENTIAL — U.S. Official Store
• FASHIONSNAP — Interview with TENTIAL CEO Yutaro Nakanishi, January 2026 (Japanese)
• PMDA — Medical Device Notification Procedures (Japanese)
• FDA — How to Determine if Your Product Is a Medical Device
• FTC — Health Products Compliance Guidance
• TENTIAL — Stanford University Baseball Partnership, July 2026 (Japanese)
• TENTIAL — Rintaro Sasaki Interview, July 2026 (Japanese)
• ANA — International First Class BAKUNE Introduction, March 2026 (Japanese)
• TENTIAL — ANA Partnership Development, May 2026 (Japanese)
• TENTIAL — B2B Partnerships and Operational Challenges, November 2024 (Japanese)
• TENTIAL — ROKU KYOTO Expansion, September 2026 (Japanese)

Research updated October 11, 2026. Product prices and website messaging may change. This article is an independent business and brand-strategy analysis based on publicly available information, not a clinical assessment or a determination of regulatory compliance.